Viewing Study NCT00987493


Ignite Creation Date: 2025-12-25 @ 1:22 AM
Ignite Modification Date: 2026-01-05 @ 11:43 AM
Study NCT ID: NCT00987493
Status: COMPLETED
Last Update Posted: 2019-05-15
First Post: 2009-09-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Rituximab, Bendamustine Hydrochloride, and Lenalidomide in Treating Patients With Aggressive B-Cell Lymphoma
Sponsor: Swiss Cancer Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module